| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Nadine Shehab | Q80533063 |
| Alexander J Kallen | Q106548790 | ||
| P2093 | author name string | Joseph F Perz | |
| Megan N Brown | |||
| P2860 | cites work | Injection therapy for subacute and chronic low-back pain | Q24242738 |
| Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12 | Q26864307 | ||
| Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacy. | Q30228512 | ||
| ASHP national survey of pharmacy practice in hospital settings: dispensing and administration--2011. | Q30415613 | ||
| Switching to less expensive blindness drug could save medicare part B $18 billion over a ten-year period | Q34062494 | ||
| Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy--United States, July-November 2002. | Q34170876 | ||
| Regulating compounding pharmacies after NECC. | Q34310391 | ||
| Deaths from intravenous colchicine resulting from a compounding pharmacy error--Oregon and Washington, 2007. | Q34700536 | ||
| Outbreak of adverse reactions associated with contaminated heparin | Q34893200 | ||
| Outbreak of Serratia marcescens bloodstream infections in patients receiving parenteral nutrition prepared by a compounding pharmacy | Q35008366 | ||
| An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab | Q35697390 | ||
| Hydroxyprogesterone caproate injection (makena) one year later: to compound or not to compound that is the question | Q36137974 | ||
| A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy | Q36903668 | ||
| Sphingomonas paucimobilis bloodstream infections associated with contaminated intravenous fentanyl | Q37139971 | ||
| Fungal endophthalmitis associated with compounded products | Q37513509 | ||
| US outbreak investigations highlight the need for safe injection practices and basic infection control | Q37685619 | ||
| APIC position paper: safe injection, infusion, and medication vial practices in health care | Q37720137 | ||
| Avastin doesn't blind people, people blind people | Q37977621 | ||
| History of sterile compounding in U.S. hospitals: learning from the tragic lessons of the past | Q38125583 | ||
| Outbreak of bacteremia due to Burkholderia contaminans linked to intravenous fentanyl from an institutional compounding pharmacy | Q39257105 | ||
| A 1000-fold overdose of clonidine caused by a compounding error in a 5-year-old child with attention-deficit/hyperactivity disorder | Q40693717 | ||
| Pseudomonas putida septicemia in a special care nursery due to contaminated flush solutions prepared in a hospital pharmacy | Q41858508 | ||
| Clinical findings for fungal infections caused by methylprednisolone injections | Q42243236 | ||
| Hepatitis C virus infections from a contaminated radiopharmaceutical used in myocardial perfusion studies | Q43032750 | ||
| Endophthalmitis outbreak associated with repackaged bevacizumab | Q43092875 | ||
| Developing entry-level competencies in sterile product preparation: an emerging challenge for pharmacy schools and experiential practice sites | Q44048300 | ||
| Growth of spinal interventional pain management techniques: analysis of utilization trends and Medicare expenditures 2000 to 2008. | Q44244731 | ||
| Enterobacter cloacae bloodstream infections in pediatric patients traced to a hospital pharmacy | Q44533154 | ||
| Assessment of the growth of epidural injections in the medicare population from 2000 to 2011. | Q44894220 | ||
| Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringes | Q44991329 | ||
| Outbreak of Serratia marcescens infections following injection of betamethasone compounded at a community pharmacy | Q46058271 | ||
| Spinal injections: trends in the US outpatient population | Q46187619 | ||
| A randomized trial of epidural glucocorticoid injections for spinal stenosis | Q47848732 | ||
| Back to the future: the end of the steroid century? | Q48460433 | ||
| An outbreak of postoperative gram-negative bacterial endophthalmitis associated with contaminated trypan blue ophthalmic solution. | Q50453127 | ||
| Instruction on compounded sterile preparations at U.S. schools of pharmacy | Q50463702 | ||
| USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy. | Q53632694 | ||
| Bevacizumab versus Ranibizumab for AMD | Q63664820 | ||
| Fungal infections associated with contaminated methylprednisolone injections | Q64127958 | ||
| Life-threatening sepsis caused by Burkholderia cepacia from contaminated intravenous flush solutions prepared by a compounding pharmacy in another state | Q79754403 | ||
| Improving and enforcing compounding pharmacy practices to protect patients | Q80187434 | ||
| Safe preparation and administration of intravitreal bevacizumab injections | Q82850729 | ||
| Product-related adverse events in hemodialysis patients: improving recognition and response | Q84149895 | ||
| P433 | issue | 3 | |
| P921 | main subject | public health | Q189603 |
| lessons learned | Q1673259 | ||
| next pandemic | Q88835036 | ||
| P304 | page(s) | 164-173 | |
| P577 | publication date | 2018-09-01 | |
| P1433 | published in | Journal of patient safety | Q27722373 |
| P1476 | title | U.S. Compounding Pharmacy-Related Outbreaks, 2001-2013: Public Health and Patient Safety Lessons Learned | |
| P478 | volume | 14 |
| Q58567666 | Evaluation of aflibercept and ziv-aflibercept binding affinity to vascular endothelial growth factor, stability and sterility after compounding | cites work | P2860 |
Search more.